Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis. Sands BE, Feagan BG, Peyrin-Biroulet L, Danese S, et al. N Engl J Med 2024;391:1119-1129.

Read + Share

Amedeo Smart

Independent Medical Education

Sands BE, Feagan BG, Peyrin-Biroulet L, Danese S, et al. Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis. N Engl J Med 2024;391:1119-1129.
PMID: 39321363